Home › NDC Lookup › RxCUI directory › RxCUI 197670

Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet — RxCUI 197670

RxNorm drug concept · Semantic clinical drug
RxCUI 197670 Semantic clinical drug · SCD ● Current RxNorm concept 22 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197670
Official nameEstrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asEEMT DS Oral Tablet; estrogens, esterified 1.25 MG / methylTESTOSTERone 2.5 MG Oral Tablet
FDA products mapped22
Package NDCs mapped22
Reported Medicaid activity (SDUD)12 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Estrogens, esterified (USP) 1.25 MG / methyltest... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet RxCUI 197670

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Estrogens, esterified (USP) 214549
    • Methyltestosterone 6904
    • Estrogens, esterified (USP) / methyltestosterone 1007348
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Covaryx 705916
    • Estratest 216989
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Estrogens, esterified (USP) / methyltestosterone Oral Tablet 378838
    • Estrogens, esterified (USP) / methyltestosterone Oral Product 1165795
    • Estrogens, esterified (USP) / methyltestosterone Pill 1165796
    • Estrogens, esterified (USP) / methyltestosterone Oral Tablet [Covaryx] 705918
    • Estrogens, esterified (USP) / methyltestosterone Oral Tablet [Estratest] 369404
    • Covaryx Oral Product 1172363
    • Covaryx Pill 1172364
    • Estratest Oral Product 1170439
    • +4 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Estrogens, esterified (USP) 1.25 MG 343072
    • Methyltestosterone 2.5 MG 316290
    • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Covaryx] 705919
    • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Estratest] 209253
    • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG [Covaryx] 705917
    • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG [Estratest] 569877

Showing up to 8 concepts per family — 19 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Estrogens, esterified (USP) 1.25 MG SCDC · 343072
  • Methyltestosterone 2.5 MG SCDC · 316290
  • Estrogens, esterified (USP) / methyltestosterone Oral Tablet SCDF · 378838
  • Estrogens, esterified (USP) / methyltestosterone Oral Product SCDG · 1165795
  • Estrogens, esterified (USP) / methyltestosterone Pill SCDG · 1165796

Brand-Name Concepts

  • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Estratest] SBD · 209253
  • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Covaryx] SBD · 705919
  • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG [Covaryx] SBDC · 705917
  • Estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG [Estratest] SBDC · 569877
  • Estrogens, esterified (USP) / methyltestosterone Oral Tablet [Covaryx] SBDF · 705918
  • Estrogens, esterified (USP) / methyltestosterone Oral Tablet [Estratest] SBDF · 369404
  • Covaryx Oral Product SBDG · 1172363
  • Covaryx Pill SBDG · 1172364
  • Estratest Oral Product SBDG · 1170439
  • Estratest Pill SBDG · 1170440

📦 FDA Products & Package NDCs

22 products · 22 package NDCs
22 package NDCs map to RxCUI 197670 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51293-0639-01 100 TABLET in 1 BOTTLE (51293-639-01) Esterified Estrogens and Methyltestosterone ECI Pharmaceuticals LLC 2020-12-15
51293-0640-01 100 TABLET in 1 BOTTLE (51293-640-01) Esterified Estrogens and Methyltestosterone ECI Pharmaceuticals LLC 2020-12-15
53746-0077-01 100 TABLET in 1 BOTTLE (53746-077-01) Esterified Estrogens and Methyltestosterone Amneal Pharmaceuticals of New York LLC 2010-09-22
53746-0078-01 100 TABLET in 1 BOTTLE (53746-078-01) Esterified Estrogens and Methyltestosterone Amneal Pharmaceuticals of New York LLC 2010-09-22
58657-0403-01 100 TABLET in 1 BOTTLE (58657-403-01) ESTRATEST H.S. Method Pharmaceuticals, LLC 2024-06-15
58657-0404-01 100 TABLET in 1 BOTTLE (58657-404-01) ESTRATEST F.S. Method Pharmaceuticals, LLC 2024-06-15
58657-0407-01 100 TABLET in 1 BOTTLE (58657-407-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Method Pharmaceuticals, LLC 2024-06-15
58657-0408-01 100 TABLET in 1 BOTTLE (58657-408-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Method Pharmaceuticals, LLC 2024-06-15
58657-0416-01 100 TABLET in 1 BOTTLE (58657-416-01) Estratest HS Method Pharmaceuticals 2025-03-10
58657-0417-01 100 TABLET in 1 BOTTLE (58657-417-01) Estratest FS Method Pharmaceuticals 2025-03-10
58657-0418-01 100 TABLET in 1 BOTTLE (58657-418-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH Method Pharmaceuticals, LLC 2025-03-10
58657-0419-01 100 TABLET in 1 BOTTLE (58657-419-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE FULL STRENGTH Method Pharmaceuticals, LLC 2025-03-10
62559-0149-01 100 TABLET in 1 BOTTLE (62559-149-01) Esterified Estrogens and Methyltestosterone ANI Pharmaceuticals, Inc. 2010-12-22
62559-0150-01 100 TABLET in 1 BOTTLE (62559-150-01) Esterified Estrogens and Methyltestosterone ANI Pharmaceuticals, Inc. 2010-12-22
63629-1979-01 100 TABLET in 1 BOTTLE (63629-1979-1) Esterified Estrogens and Methyltestosterone Bryant Ranch Prepack 2021-01-15
69315-0283-01 100 TABLET in 1 BOTTLE (69315-283-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Leading Pharmaceuticals, LLC 2022-10-01
69315-0284-01 100 TABLET in 1 BOTTLE (69315-284-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Leading Pharmaceuticals, LLC 2022-10-01
72162-1747-01 100 TABLET in 1 BOTTLE (72162-1747-1) Esterified Estrogens and Methyltestosterone Bryant Ranch Prepack 2025-02-04
72162-2392-01 100 TABLET in 1 BOTTLE (72162-2392-1) ESTRATEST F.S. Bryant Ranch Prepack 2026-03-17
72162-2393-01 100 TABLET in 1 BOTTLE (72162-2393-1) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Bryant Ranch Prepack 2026-03-17
82619-0136-01 100 TABLET in 1 BOTTLE (82619-136-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Creekwood Pharmaceuticals LLC 2026-01-12
82619-0137-01 100 TABLET in 1 BOTTLE (82619-137-01) ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE Creekwood Pharmaceuticals LLC 2026-01-12
Observed labelers: Method Pharmaceuticals, LLC (6) · Bryant Ranch Prepack (4) · Amneal Pharmaceuticals of New York LLC (2) · ANI Pharmaceuticals, Inc. (2) · Creekwood Pharmaceuticals LLC (2) · ECI Pharmaceuticals LLC (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.